You can buy or sell VBI Vaccines and other stocks, options, ETFs, and crypto commission-free!
VBI Vaccines, Inc. New Common Stock (Canada), also called VBI Vaccines, is a biopharmaceutical company, which engages in the development of vaccines for infectious disease and immuno-oncology. Read More Its pipeline include HBV Therapeutic,HBV Prophylaxis, CMV Propylaxis, GBM Immunotherapy, MB Immunotherapy, and Zika Propylaxis. The company was founded on July 9, 2015 is headquartered in Cambridge, MA.
52 Week High
52 Week Low
Yahoo FinanceMay 1
VBI Vaccines, Inc. (VBIV) Reports Q1 Loss, Tops Revenue Estimates
Fortis (FTS) delivered earnings and revenue surprises of -1.79% and 6.27%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Yahoo FinanceApr 30
VBI Vaccines, Inc. (VBIV) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
VBI Vaccines, Inc. (VBIV) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2019. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price. The earnings report might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, ...
Expected Jul 25, Pre-Market